Biomerica Inc (BMRA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biomerica Inc (BMRA) has a cash flow conversion efficiency ratio of -0.377x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.25 Million) by net assets ($3.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Biomerica Inc (BMRA) net asset quality to measure how much of total assets are equity-financed.
Biomerica Inc - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Biomerica Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BMRA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Biomerica Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biomerica Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Carmell Therapeutics Corporation
NASDAQ:CTCX
|
0.198x |
|
Picton Property Income Ltd
LSE:PCTN
|
0.018x |
|
Jain Irrigation Systems Limited
NSE:JISLDVREQS
|
0.032x |
|
Sentral Mitra Informatika Tbk PT
JK:LUCK
|
-0.026x |
|
PLENUM AG NA O.N.
F:PLEK
|
N/A |
|
Sentage Holdings Inc
NASDAQ:SNTG
|
-0.060x |
|
Alpha Compute Corp
NASDAQ:ALP
|
-0.080x |
|
Blue Coast Hotels Limited
NSE:BLUECOAST
|
0.010x |
Annual Cash Flow Conversion Efficiency for Biomerica Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of Biomerica Inc from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see Biomerica Inc (BMRA) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-05-31 | $4.11 Million | $-3.84 Million | -0.936x | -15.04% |
| 2024-05-31 | $6.59 Million | $-5.36 Million | -0.813x | -74.21% |
| 2023-05-31 | $11.72 Million | $-5.47 Million | -0.467x | -708.86% |
| 2022-05-31 | $8.32 Million | $-480.53K | -0.058x | +89.86% |
| 2021-05-31 | $9.23 Million | $-5.25 Million | -0.569x | -88.24% |
| 2020-05-31 | $14.21 Million | $-4.30 Million | -0.302x | +46.36% |
| 2019-05-31 | $3.98 Million | $-2.24 Million | -0.564x | -107.66% |
| 2018-05-31 | $4.33 Million | $-1.17 Million | -0.271x | -68.57% |
| 2017-05-31 | $4.49 Million | $-722.86K | -0.161x | -302.63% |
| 2016-05-31 | $5.22 Million | $-208.78K | -0.040x | +44.76% |
| 2015-05-31 | $5.60 Million | $-405.48K | -0.072x | +50.34% |
| 2014-05-31 | $5.91 Million | $-862.27K | -0.146x | -161.02% |
| 2013-05-31 | $5.83 Million | $1.39 Million | 0.239x | +706.88% |
| 2012-05-31 | $4.98 Million | $147.41K | 0.030x | -61.00% |
| 2011-05-31 | $4.33 Million | $328.80K | 0.076x | +230.18% |
| 2010-05-31 | $4.06 Million | $-236.98K | -0.058x | -148.64% |
| 2009-05-31 | $4.35 Million | $-102.00K | -0.023x | +53.18% |
| 2008-05-31 | $3.88 Million | $-194.59K | -0.050x | -118.94% |
| 2007-05-31 | $1.75 Million | $463.71K | 0.265x | +173.07% |
| 2006-05-31 | $1.06 Million | $-385.17K | -0.362x | -1854.28% |
| 2005-05-31 | $3.53 Million | $72.92K | 0.021x | +196.65% |
| 2004-05-31 | $3.51 Million | $-75.03K | -0.021x | -113.52% |
| 2003-05-31 | $3.25 Million | $512.54K | 0.158x | +497.02% |
| 2002-05-31 | $3.30 Million | $-131.07K | -0.040x | -228.48% |
| 2001-05-31 | $3.52 Million | $108.95K | 0.031x | +105.93% |
| 2000-05-31 | $4.91 Million | $-2.56 Million | -0.522x | -709.72% |
| 1999-05-31 | $6.20 Million | $-400.00K | -0.065x | -200.00% |
| 1998-05-31 | $6.20 Million | $400.00K | 0.065x | -45.62% |
| 1997-05-31 | $5.90 Million | $700.00K | 0.119x | -2.71% |
| 1996-05-31 | $4.10 Million | $500.00K | 0.122x | -21.95% |
| 1995-05-31 | $3.20 Million | $500.00K | 0.156x | -48.44% |
| 1994-05-31 | $3.30 Million | $1.00 Million | 0.303x | +312.12% |
| 1993-05-31 | $2.80 Million | $-400.00K | -0.143x | +17.86% |
| 1992-05-31 | $2.30 Million | $-400.00K | -0.174x | -139.53% |
| 1991-05-31 | $2.50 Million | $1.10 Million | 0.440x | +1112.00% |
| 1990-05-31 | $4.60 Million | $-200.00K | -0.043x | +76.09% |
| 1989-05-31 | $3.30 Million | $-600.00K | -0.182x | -- |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and oth… Read more